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Treprostinil sodium, as a prostacyclin ana-
logue, is a specific drug used for treatment of 
pulmonary arterial hypertension (PAH) [1]. One 
way of administration — intravenous — may be 
provided by implantation of a subcutaneous pump 
(LenusPro®) in the subcostal region. It administers 
the drug continuously to the superior caval vein 
by means of a catheter inserted through the sub-
clavian vein [2–4]. This method is generally safe 
and adverse events occur rarely [5].
A 38-year-old man with PAH treated with 
treprostinil had a LenusPro® pump (Fig. 1A, E) 
implanted. The chest X-ray after 2 months revealed 
the tip of the catheter placed in the right internal 
jugular vein (Fig. 1B). As the patient had been in 
a good clinical condition, we decided to observe 
it. Four months after implantation the patient 
reported a strong pain and swelling in the right 
subclavian region without significant clinical dete-
rioration. The chest X-ray revealed the tip of the 
catheter below the right clavicle (Fig. 1C) — the 
catheter slipped out of the vascular system and the 
drug was being delivered into the soft tissues. Due 
to tissue edema, the repositioning of the catheter 
attempted in the implanting center was difficult 
and required carrying the cannula through the su-
praclavicular region into the right internal jugular 
vein (Fig. 1D). After next 2 months, while checking 
the position of the catheter in the fluoroscopy, we 
suspected another dislocation (Fig. 1F). On closer 
assessment in the implanting center, the cannula 
was seen to be folding and straightening in the 
jugular vein broadened due to chronically elevated 
pressure (Fig. 1G, H). This time the cannula ap-
parently remained within the vascular lumen and 
those moves did not result in clinical deterioration 
of the patient’s condition during several months 
of follow-up. However, the residual volume in the 
pump had been higher than expected and finally 
the outflow stopped, giving an alarm. This time 
the patient required an urgent repositioning of 
the catheter, which were placed again through the 
proximal subclavian vein, whereas the distal part 
appeared to be occluded with well-developed col-
lateral circulation.
In patients with PAH and a LenusPro® pump 
for treprostinil infusion, there is a possibility for 
catheter dislocation. It is reasonable to check the 
position of the catheter regularly with an imaging 
method (i.e. chest X-ray, fluoroscopy). A strong 
pain in the subclavian region may suggest that 
the cannula is slipping out of the subclavian vein. 
In the presented case, such a situation required 
urgent repositioning of the catheter due to the 
pain and worse absorption of the drug from the 
soft tissues. An unstable position of the tip of the 
cannula without its slipping outside the vessel also 
does not appear to be benign, because one day it 
may result in complete wedging of the catheter 
with an outflow blockade.
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Figure 1. A patient with pulmonary arterial hypertension and a subcutaneous pump for continuous intravenous infu-
sion of treprostinil (E) — different configuration of the distal part of the drug administering cannula (white arrows) — 
dates (DD-MM): A. 15-04 (baseline); B. 10-06 (the tip in the right internal jugular vein); C. 10-08 (the cannula slipped 
out of the subclavian vein); D. 12-08 (after repositioning); F. 27-10 (a loop in right internal jugular vein); G. 28-10; 
H. 29-10 (spontaneous stretching of the catheter).
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